Authors: Comba, AZ Blajman, C Richardet, E Bella, S Vilanova, M Coppola, F Van Kooten, M Rodger, J Giglio, R Balbiani, L Perazzo, F Montiel, M Chacon, M Pujol, F Mickiewicz, E Cazap, E Recondo, G Lastiri, F Simon, J Wasserman, E Schmilovich, A

Citation: Az. Comba et al., A randomised phase II study of oxaliplatin alone versus oxaliplatin combined with 5-fluorouracil and folinic acid (Mayo Clinic regimen) in previouslyuntreated metastatic colorectal cancer patients, EUR J CANC, 37(8), 2001, pp. 1006-1013

Authors: Lhomme, C Vermorken, JB Mickiewicz, E Chevalier, B Alvarez, A Mendiola, C Pawinski, A Lentz, MA Pecorelli, S

Citation: C. Lhomme et al., Phase II trial of vinorelbine in patients with advanced and/or recurrent cervical carcinoma: an EORTC Gynaecological Cancer Cooperative Group Study, EUR J CANC, 36(2), 2000, pp. 194-199

Authors: Lonning, PE Bajetta, E Murray, R Tubiana-Hulin, M Eisenberg, PD Mickiewicz, E Celio, L Pitt, P Mita, M Aaronson, NK Fowst, C Arkhipov, A di Salle, E Polli, A Massimini, G

Citation: Pe. Lonning et al., Activity of exemestane in metastatic breast cancer after failure of nonsteroidal aromatase inhibitors: A phase II trial, J CL ONCOL, 18(11), 2000, pp. 2234-2244

Authors: Richardet, E Pedraza, C Mickiewicz, E Lerzo, G Bonamasa, M Coppola, F Elli, A Uranga, G Jovtis, S Bruno, M Ventriglia, M Cuevas, MA Alvarez, AM Suarez, LA Fein, L

Citation: E. Richardet et al., Uracil/tegafur plus oral calcium folinate in advanced breast cancer, ONCOLOGY-NY, 13(7), 1999, pp. 96-97

Authors: Pazos, C Mickiewicz, E Di Notto, MR Coppola, F Ventriglia, M Jovtis, S Balbiani, L Lewi, D Rondinon, M Temperley, G Trigo, M Bertoncin, AM Pascual, M Uranga, G Cazap, E Breier, S Grasso, S Estevez, R Triguboff, E Alvarez, A Suarez, A

Citation: C. Pazos et al., Phase II of doxorubicin taxol in metastatic breast cancer, BREAST CANC, 55(1), 1999, pp. 91-96